Indication

Oral candidiasis

Oral candidiasis is an opportunistic fungal infection of the oral cavity and mucous membranes caused by an overgrowth of *Candida* species, predominantly *Candida albicans*. Read more about Oral candidiasis

84 drugs 72 manufacturers

Advertisement

Drugs that treat it

Common Oral candidiasis therapies.

Showing 19–27 of 84 drugs

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS·ORAL CANDIDIASIS·+2
PHARMACEU ASSOC

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC·ORAL CANDIDIASIS·+11
Mylan Pharmaceuticals

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC·ORAL CANDIDIASIS·+11
GLENMARK PHARMA

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC·ORAL CANDIDIASIS·+11
GREENSTONE LLC.

NYSTATIN

ORAL CANDIDIASIS·+2
HERITAGE PHARMA
Filter & compare in the drug finder →Opens the drug finder with Oral candidiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Oral candidiasis.

Oral candidiasis is an opportunistic fungal infection of the oral cavity and mucous membranes caused by an overgrowth of *Candida* species, predominantly *Candida albicans*.

It commonly affects neonates, older adults, denture wearers, and individuals with local or systemic immunosuppression, including patients using inhaled corticosteroids or broad-spectrum antibiotics, as well as those with diabetes mellitus or HIV/AIDS.

Pathophysiologically, the condition occurs when disruptions in mucosal barrier integrity, salivary flow, or host immune defenses allow commensal yeasts to transform into invasive hyphal forms.

Clinical presentations typically manifest as wipeable white pseudomembranous plaques over an erythematous base, burning erythematous mucosal lesions, or chronic hyperplastic plaques, often accompanied by oral pain, altered taste, or dysphagia.

Personalize your experience

Follow Oral candidiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it